Your browser doesn't support javascript.
loading
What role for AHR activation in IL4I1-mediated immunosuppression ?
Castellano, Flavia; Prevost-Blondel, Armelle; Cohen, José L; Molinier-Frenkel, Valérie.
Affiliation
  • Castellano F; INSERM, IMRB, Univ Paris Est Creteil, Creteil, France.
  • Prevost-Blondel A; Departement d'Hematologie-Immunologie, AP-HP, Hopital Henri Mondor, Créteil, France.
  • Cohen JL; INSERM, CNRS, Université de Paris, Institut Cochin, PARIS, France.
  • Molinier-Frenkel V; INSERM, IMRB, Univ Paris Est Creteil, Creteil, France.
Oncoimmunology ; 10(1): 1924500, 2021 05 12.
Article in En | MEDLINE | ID: mdl-34026337
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Activation / Immunosuppression Therapy / Receptors, Aryl Hydrocarbon / L-Amino Acid Oxidase / Basic Helix-Loop-Helix Transcription Factors Limits: Humans Language: En Journal: Oncoimmunology Year: 2021 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Activation / Immunosuppression Therapy / Receptors, Aryl Hydrocarbon / L-Amino Acid Oxidase / Basic Helix-Loop-Helix Transcription Factors Limits: Humans Language: En Journal: Oncoimmunology Year: 2021 Document type: Article Affiliation country: France Country of publication: United States